monitoring of daunorubicin ( dnr ) concentrations in leukemic cells in blood and bone marrow in vivo of patients with acute myeloid leukemia may yield insight into the interindividual variations of the clinical response to treatment .
C0011015
daunorubicin
C0023467
acute myeloid leukemia